NCT04913753 (AblaJ) is a NA clinical trial of CBEU in Urinary Infection, sponsored by University Hospital, Tours.

Who is sponsoring NCT04913753?

NCT04913753 is sponsored by University Hospital, Tours.

What drugs are being tested in NCT04913753?

Interventions in NCT04913753: CBEU, No CBEU.

What condition does NCT04913753 study?

NCT04913753 studies Urinary Infection.

Is NCT04913753 still recruiting?

NCT04913753 is currently completed. Last updated 12 December 2025.

Last reviewed 2025-12-12 · How we verify

NCT04913753: AblaJ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relevance of the Urine Bacterial Culture Performed Before Double J Ablation for Post-operative Urinary Tract Infection Prevention

Completed NA Last updated 12 December 2025

What this trial tests

NA trial testing CBEU in Urinary Infection in 2,200 participants. Completed in 3 December 2025.

Timeline

10 June 2021

Primary endpoint
3 December 2025

3 December 2025

Quick facts

Lead sponsor	University Hospital, Tours
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	2,200
Start date	10 June 2021
Primary completion	3 December 2025
Estimated completion	3 December 2025
Sites	1 location across France

Drugs / interventions tested

CBEU
No CBEU

Conditions studied

Urinary Infection — all drugs for Urinary Infection →

Sponsor

University Hospital, Tours

Who can join

Adults 18 to 100, any sex, with Urinary Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The value of cytobacteriological examination of urine (CBEU) before double J catheter removal has not been demonstrated. The aim of this study is to define the interest of this CBEU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Tours trials

Trials by the same sponsor.

NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04913753 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
Last refreshed: 12 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04913753.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing